Pathophysiology of asthma

British Journal of Clinical Pharmacology

Volumn 42, Issue 1, 1996, Pages 3-10

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Eosinophils; Epithelial cells; Inflammation; Inflammatory mediators; Neuropeptides; T lymphocytes; Transcription factors

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CYTOKINE; ENDOTHELIN; LEUKOTRIENE; NEUROPEPTIDE; NITRIC OXIDE; TRANSCRIPTION FACTOR;

ASTHMA; CONFERENCE PAPER; GENE EXPRESSION; INFLAMMATION; INFLAMMATORY CELL; LUNG FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029999428     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03721.x     Document Type: Conference Paper

References (61)

1. Dunnill MS. The pathology of asthma, with special reference to the changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.
2. Djukanovic R, Roche UR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
3. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989; 83: 1013-1026.
4. Barnes PJ. New aspects of asthma. J Int Med 1992; 231: 453-461.
5. Lee TM, Lane SJ. The role of macrophages in the mechanisms of airway inflammation in asthma. Am Rev Respir Dis 1992; 145: S27-30.
6. Spiteri MA, Knight RA, Jeremy JY, Barnes PJ, Chung KF. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Resp J 1994; 7: 1431-1438.
7. Holt PG. Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur Respir J 1993; 6: 120-129.
8. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990; 85, 422-436.
9. Wegner CD, Gundel L, Reilly P, Haynes N, Letts LG, Rothlein R. Intracellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247: 456-459.
10. Pilewski JM, Albelda SM. Cell adhesion molecules in asthma: homing, activation and airway remodelling. Am J Respir Cell Mol Biol 1995; 12: 1-3.
11. Lamas AM, Mulroney CM, Schleimer RP. Studies of the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol 1988; 140: 1500-1510.
12. Barnes PJ, Chung KF, Page CP. Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol 1988; 81: 919-934.
13. Barnes PJ. Cytokines as mediators of chronic asthma. Am J Resp Crit Care Med 1994; 150: S42-S49.
14. Chanez P, Dent G, Yukawa T, Barnes PJ, Chung KF. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur Respir J 1990; 3: 1002-1007.
15. Evans DJ, Lindsay MA, O'Connor BJ, Barnes PJ. Priming of circulating human eosinophils following exposure to allergen challenge. Eur Respir J 1996; (in press).
16. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 1995; 12: 488-496.
17. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179: 881-887.
18. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87: 893-913.
19. Devalia JL, Davies RJ. Airway epithelial cells and mediators of inflammation. Resp Med 1993; 6: 405-408.
20. Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev 1988; 40: 49-84.
21. Barnes PJ, Chung KF, Page CP. Inflammatory mediators and asthma. Pharmacol Rev 1996; (in press).
22. Arm JP, Lee TH. Sulphidopeptide leukotrienes in asthma. Clin Sci 1993; 84: 501-510.
23. 4-receptor antagonist. New Engl J Med 1990; 323: 1736-1739.
24. Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991; 337: 690-694.
25. 4 receptor antagonist in subjects with bronchial asthma. Am J Resp Crit Care Med 1994; 150: 618-623.
26. Spence DPS, Johnston SL, Calverley PMA, et al. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am J Resp Crit Care Med 1994; 149: 1142-1148.
27. Kuitert LM, Angus RM, Barnes NC, et al. The effect of a novel potent PAF antagonist, modipafant, in chronic asthma. Am J Respir Crit Care Med 1995; 151: 1331-1335.
28. Hamid Q, Azzawi M, Sun Ying, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541-1549.
29. Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-a increases airway responsiveness and sputum neutrophils in normal human subjects. Am J Respir Crit Care Med 1995; 152: 76-80.
30. Barnes PJ. Endothelins and pulmonary diseases. J Appl Physiol 1994; 77: 1051-1059.
31. Springall DR, Howarth PH, Counihan H, Djukanovic R, Holgate ST, Polak JM. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 1991; 337: 697-701.
32. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995; 27: 91-97.
33. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510-1513.
34. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 1994; 203: 209-218.
35. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne E, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
36. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995; 16: 128-130.
37. Bai TR, Mak JCW, Barnes PJ. A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 1992; 6: 647-651.
38. Grandordy BM, Mak JCW, Barnes PJ. Modulation of airway smooth muscle b-adrenoceptor function by a muscarinic agonist. Life Sci 1994; 54: 185-191.
39. Ebina M, Yaegashi H, Chiba R, Takahashi T, Motomiya M, Tanemura M. Hyperreactive site in the airway tree of asthmatic patients recoded by thickening of bronchial muscles: a morphometric study. Am Rev Respir Dis 1990; 141: 1327-1332.
40. Persson CGA. Plasma exudation and asthma. Lung 1988; 166: 1-23.
41. Chung KF, Rogers DF, Barnes PJ, Evans TW. The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J 1990; 3: 329-337.
42. Kuo H, Rhode JAL, Tokuyama K, Barnes PJ, Rogers DF. Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea pig trachea. J Physiol 1990; 431: 629-641.
43. Barnes PJ. Is asthma a nervous disease? The Parker B Francis Lecture. Chest 1995; 107: 119S-124S.
44. Barnes PJ, Baraniuk J, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144: 1187-1198, 1391-1399.
45. Barnes PJ. Modulation of neurotransmission in airways. Physiol Rev 1992; 72: 699-729.
46. Lammers JWJ, Barnes PJ, Chung KF. Non-adrenergic, non-cholinergic airway inhibitory nerves. Eur Respir J 1992; 5: 239-246.
47. Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 1989; 320: 1244-1248.
48. Barnes PJ. Vasoactive intestinal peptide and asthma. N Engl J Med 1989; 321: 1128-1129.
49. Belvisi MG, Stretton CD, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways. Eur J Pharmacol 1992; 210: 221-222.
50. Barnes PJ. Sensory nerves, neuropeptides and asthma. Ann NY Acad Sci 1991; 629: 359-370.
51. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and non-asthmatics. Eur Respir J 1991; 4: 673-682.
52. Nadel JA. Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 1991; 4: 745-754.
53. Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol 1993; 11: 1-7.
54. Barnes PJ, Adcock IM. Transcription factors in asthma. Clin Exp Allergy 1995; 27 (Suppl 2): 46-49.
55. Siebenlist U, Franzuso G, Brown R. Structure, regulation and function of NF-κB. Ann Rev Cell Biol 1994; 10: 405-455.
56. Barnes PJ, Karin M. NF-kappa B: pivotal role in chronic inflammation. N Engl J Med 1996; (in press).
57. Barnes PJ, Adcock IM. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-441.
58. Barnes PJ. A new approach to asthma therapy. J Med 1989; 321: 1517-1527.
59. Barnes PJ. Inhaled glucocorticoids for asthma. J Med 1995; 332: 868-875.
60. 2-agonists in asthma. Trends Pharmacol Sci 1992; 13: 20-23.
61. Haahtela T, Järvinsen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.